These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5519324)

  • 1. [Therapy of chronic-obstructive ailments of the respiratory tract].
    Virchow C; Debelic M
    Schweiz Rundsch Med Prax; 1970 Jan; 59(1):24-8. PubMed ID: 5519324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sobrerol for the treatment of chronic obstructive bronchopneumopathies (clinical and functional observations)].
    Dotta F; Bianchi A
    Policlinico Med; 1971; 78(2):82-90. PubMed ID: 5564823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
    Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
    Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences in the treatment of bronchospastic diseases].
    Klein HG
    Med Welt; 1967 Nov; 45():2718-21. PubMed ID: 5609213
    [No Abstract]   [Full Text] [Related]  

  • 5. The status of bronchodilator treatment.
    Clark TJ
    Postgrad Med J; 1971 Mar; 47():Suppl:50-3. PubMed ID: 5572517
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with guacetisal].
    Minerva Med; 1981 Feb; 72(7):321-462. PubMed ID: 7243037
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhalation therapy using glucocorticosteroids].
    Ferlinz R
    Med Klin; 1971 May; 66(19):716-22. PubMed ID: 4995661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current therapy for chronic respiratory tract diseases].
    Hoffarth HP; Ulmer WT
    Dtsch Med Wochenschr; 1990 Jan; 115(2):63-6. PubMed ID: 2403913
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of expectorants.
    Hirsch SR
    Wis Med J; 1971 May; 70(5):153-6. PubMed ID: 4941901
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airways disease.
    Sadoul P; Sentissi M
    Postgrad Med J; 1971 Mar; 47():Suppl:111-2. PubMed ID: 5572508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Criteria of drug testing in industrial practice, demonstrated by a cough remedy].
    Nesswetha W
    Arzneimittelforschung; 1967 Oct; 17(10):1324-6. PubMed ID: 4885305
    [No Abstract]   [Full Text] [Related]  

  • 13. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 14. Important aspects of pulmonary rehabilitation.
    McDonald GJ; Hudson LD
    Geriatrics; 1982 Mar; 37(3):127-32, 134. PubMed ID: 6121740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Over-8-hour salbutamol effect in obstructive respiratory tract diseases].
    Kersten W
    Fortschr Med; 1974 Apr; 92(11):487-91. PubMed ID: 4822455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observations on the effects of the association of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride and oxytetracycline in acute and chronic bronchopathies].
    Bini P; Romagnoli E
    Clin Ter; 1970 Dec; 55(5):433-59. PubMed ID: 5516108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion].
    Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP
    Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines].
    Holmen TL; Selvig K; Bjerve KS; Aas K; Rugstad HE
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):172-73. PubMed ID: 7385142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.